CLA and PPARγ synthetic agonist induced a significant increase of GFAP protein levels as well as the acquirement of the astrocytic phenotype indicating that activated-PPARγ induces differentiation of glioblastoma cells. This evidence concerns the gene PPARG and glioblastoma.